Clinical comparisons between post-traumatic headache and migraine: A cross-sectional study.

IF 4.6 2区 医学 Q1 CLINICAL NEUROLOGY
Cephalalgia Pub Date : 2025-04-01 Epub Date: 2025-04-29 DOI:10.1177/03331024251331605
Haidar M Al-Khazali, Rune H Christensen, Håkan Ashina
{"title":"Clinical comparisons between post-traumatic headache and migraine: A cross-sectional study.","authors":"Haidar M Al-Khazali, Rune H Christensen, Håkan Ashina","doi":"10.1177/03331024251331605","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveTo compare clinical characteristics, treatment patterns, and patient-reported outcome measures (PROMs) in persons with persistent post-traumatic headache (PTH) and those with episodic or chronic migraine (with and without medication-overuse headache).MethodsThis cross-sectional study included adults with persistent PTH following mild traumatic brain injury and adults with episodic or chronic migraine. Information on headache features, treatment patterns, and PROMs were collected via semi-structured interviews and standardized questionnaires, including the HIT-6, MIDAS, HADS, ASC-12, CSI, WHODAS-2.0, NDI, and ODI.ResultsA total of 132 participants with persistent PTH and 751 with migraine were enrolled. On average, participants with persistent PTH reported 27.2 ± 9.3 monthly headache days, and 93.9% had a migraine-like phenotype. Compared with episodic migraine, the persistent PTH group had higher MIDAS scores (72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8]; <i>P</i> < 0.001), HADS-Anxiety (6.0 [IQR, 3.3-9.0] vs. 5.0 [IQR, 3.0-7.0]; <i>P</i> = 0.003), higher HADS-Depression scores (6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0]; <i>P</i> < 0.001), CSI (67.2 [SD, 15.0] vs. 57.4 [SD, 12.5]; <i>P</i> = 0.002), WHODAS-2.0 (41.0 [IQR, 15.5-68.5] vs. 22.0 [IQR, 10.0-35.0]; <i>P </i>< 0.001), and NDI (21.0 [IQR, 16.0-27.0] vs. 14.5 [IQR, 8.0-22.0]; <i>P </i>= 0.007). No marked differences were noted between the PTH group and chronic migraine groups.ConclusionsPersons with persistent PTH show similar disability and headache profiles to those with chronic migraine. These findings underscore the need for targeted management strategies, similar to those used in chronic migraine care.</p>","PeriodicalId":10075,"journal":{"name":"Cephalalgia","volume":"45 4","pages":"3331024251331605"},"PeriodicalIF":4.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cephalalgia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03331024251331605","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

ObjectiveTo compare clinical characteristics, treatment patterns, and patient-reported outcome measures (PROMs) in persons with persistent post-traumatic headache (PTH) and those with episodic or chronic migraine (with and without medication-overuse headache).MethodsThis cross-sectional study included adults with persistent PTH following mild traumatic brain injury and adults with episodic or chronic migraine. Information on headache features, treatment patterns, and PROMs were collected via semi-structured interviews and standardized questionnaires, including the HIT-6, MIDAS, HADS, ASC-12, CSI, WHODAS-2.0, NDI, and ODI.ResultsA total of 132 participants with persistent PTH and 751 with migraine were enrolled. On average, participants with persistent PTH reported 27.2 ± 9.3 monthly headache days, and 93.9% had a migraine-like phenotype. Compared with episodic migraine, the persistent PTH group had higher MIDAS scores (72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8]; P < 0.001), HADS-Anxiety (6.0 [IQR, 3.3-9.0] vs. 5.0 [IQR, 3.0-7.0]; P = 0.003), higher HADS-Depression scores (6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0]; P < 0.001), CSI (67.2 [SD, 15.0] vs. 57.4 [SD, 12.5]; P = 0.002), WHODAS-2.0 (41.0 [IQR, 15.5-68.5] vs. 22.0 [IQR, 10.0-35.0]; P < 0.001), and NDI (21.0 [IQR, 16.0-27.0] vs. 14.5 [IQR, 8.0-22.0]; P = 0.007). No marked differences were noted between the PTH group and chronic migraine groups.ConclusionsPersons with persistent PTH show similar disability and headache profiles to those with chronic migraine. These findings underscore the need for targeted management strategies, similar to those used in chronic migraine care.

创伤后头痛和偏头痛的临床比较:横断面研究。
目的比较持续性创伤后头痛(PTH)患者与发作性或慢性偏头痛(伴或不伴药物滥用性头痛)患者的临床特征、治疗模式和患者报告的预后指标(PROMs)。方法本横断面研究包括轻度外伤性脑损伤后持续性PTH的成人和发作性或慢性偏头痛的成人。通过半结构化访谈和标准化问卷(包括HIT-6、MIDAS、HADS、ASC-12、CSI、WHODAS-2.0、NDI和ODI)收集有关头痛特征、治疗模式和PROMs的信息。结果共纳入了132例持续性甲状旁腺激素患者和751例偏头痛患者。平均而言,持续性PTH患者每月头痛天数为27.2±9.3天,93.9%的患者有偏头痛样表型。与发作性偏头痛相比,持续性PTH组的MIDAS评分更高(72.5 [IQR, 28.0-156.0] vs. 40.0 [IQR, 20.0-62.8];P = 0.003),较高的HADS-Depression评分(6.0 [IQR, 3.0-9.0] vs. 3.0 [IQR, 1.0-5.0];P P = 0.002), whodas - 2.0(41.0(差,15.5 - -68.5)和22.0(差,10.0 - -35.0);p = 0.007)。PTH组与慢性偏头痛组间无明显差异。结论持续性甲状旁腺激素患者与慢性偏头痛患者表现出相似的残疾和头痛特征。这些发现强调了有针对性的管理策略的必要性,类似于慢性偏头痛的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cephalalgia
Cephalalgia 医学-临床神经学
CiteScore
10.10
自引率
6.10%
发文量
108
审稿时长
4-8 weeks
期刊介绍: Cephalalgia contains original peer reviewed papers on all aspects of headache. The journal provides an international forum for original research papers, review articles and short communications. Published monthly on behalf of the International Headache Society, Cephalalgia''s rapid review averages 5 ½ weeks from author submission to first decision.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信